Skip to content

Study on early prediction and pathogenesis of hypertensive diseases during pregnancy based on metabolomics

Study on early prediction and pathogenesis of hypertensive diseases during pregnancy based on metabolomics

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100046686
Enrollment
Unknown
Registered
2021-05-26
Start date
2021-05-24
Completion date
Unknown
Last updated
2022-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertensive disorders of pregnancy

Interventions

Healthy pregnancy group:No
Hypertensive disorders of pregnancy group:No

Sponsors

Shenzhen People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Single pregnancy with age >=18 years; 2. The subjects read and fully understood the instructions of the patients, and signed the informed consent; 3. At 11-13 weeks of gestation, the live fetus should be delivered in Shenzhen People's Hospital; 4. The healthy pregnancy group were pregnant women with normal blood pressure and negative proteinuria, no previous history of hypertension, diabetes, systemic lupus erythematosus, thrombotic diseases, first pregnancy or successful pregnancy, no complications, complicated with medical and surgical diseases; 5. Gestational hypertensive disease and gestational diabetes were in line with the relevant diagnostic criteria of Obstetrics and Gynecology (9th edition) published by People's Medical Publishing House.

Exclusion criteria

Exclusion criteria: 1. Multiple pregnancy; 2. Known severe fetal malformations; 3. Complicated with known serious systemic diseases, such as heart disease, liver and kidney disease, etc.

Design outcomes

Primary

MeasureTime frame
plasma metabolome;

Countries

China

Contacts

Public ContactLi Liping

Shenzhen People's Hospital

doctorliliping@foxmail.com+86 18100282893

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026